It is a healthcare public limited company based in Delhi, Delhi, India, established in 1996.
1996 | Delhi, Delhi, India | ActiveMedicross Pharma-Chem Limited, a active public limited company, was established on 30 September 1996 in Delhi, Delhi, India. Engaging in medical equipment retail & distribution within the trade sector, it holds CIN: U24231DL1996PLC082346. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹3.00 M and a paid-up capital of ₹1.60 M.
It upholds a compliant status. Its leadership includes Anu Dewan (Whole-Time Director), Tariq Masood (Whole-Time Director), Anirudh Bhardwaj (Director). Past directors included Sunil Kumar Sharma, Neeraj Deewan, Anu Dewan. It holds ₹0.20 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at F-60, Azad Apartments Plot No. 111 I.P. Extension,, Delhi, Delhi, 110092.
U24231DL1996PLC082346
082346
30 September 1996
₹3.00 M
₹1.60 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Medicross Pharma-Chem Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anu Dewan | Whole-Time Director | 26 Mar 2015 | Current |
| Tariq Masood | Whole-Time Director | 26 Mar 2015 | Current |
| Anirudh Bhardwaj | Director | 15 Mar 2017 | Current |
| Sakshi Bhardwaj | Director | 15 Mar 2017 | Current |
| Prateek Dewan | Whole-Time Director | 01 Jan 2023 | Current |
| Arif Masood | Whole-Time Director | 30 Sep 1996 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 02 May 2015 | Past |
| Pramod Abcsdd | Director | 30 Sep 2017 | Past |
| Pramod Abcsdd | Director | 23 Feb 2023 | Past |
| Pramod Abcsdd | Director | 30 Sep 2017 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2017 | Past |
| Pramod Abcsdd | Additional Director | 01 Oct 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Medicross Pharma-Chem Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 9.63% increase. The company also saw a substantial fall in profitability, with a 57.85% decrease in profit. The company's net worth moved up by a moderate rise of 5.59%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Medicross Pharma-Chem had a promoter holding of 81.50% and a public holding of 18.50%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹200,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Mar 1991 | Canara Bank | ₹0.20 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Medicross Pharma-Chem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Medicross Pharma-Chem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medicross Pharma-Chem's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Medicross Pharma-Chem Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Medicross Pharma-Chem Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.
Prateek Dewan was appointed as a Whole-time director was appointed as a Whole-time director on 01 Jan 2023 & has been associated with this company since 2 years 10 months . was recorded as a recent event.
Anirudh Bhardwaj was appointed as a Director was appointed as a Director on 15 Mar 2017 & has been associated with this company since 8 years 8 months . was recorded as a recent event.
Progress on Sakshi Bhardwaj was appointed as a Director was appointed as a Director on 15 Mar 2017 & has been associated with this company since 8 years 8 months . was documented.
Anu Dewan was appointed as a Whole-time director was appointed as a Whole-time director on 26 Mar 2015 & has been associated with this company since 10 years 8 months . was recorded as a recent event.
The CIN of Medicross Pharma-Chem Limited is U24231DL1996PLC082346.
Medicross Pharma-Chem Limited is headquartered at F-60, Azad Apartments Plot No. 111 I.P. Extension,, Delhi, Delhi, 110092.
Medicross Pharma-Chem Limited was incorporated on 30 September 1996.
The current directors of Medicross Pharma-Chem Limited are
The primary industry of Medicross Pharma-Chem Limited is Trade.
Medicross Pharma-Chem Limited is unlisted.
The authorized capital of Medicross Pharma-Chem Limited is ₹3.00 M, and the paid-up capital is ₹1.60 M.
The compliance status of Medicross Pharma-Chem Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX